In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Toxicological Sciences

• Publication date

  2012-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/toxsci/kfs188PMID 22641618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoid Type 1 Receptor Antagonists Modulate Transport Activity of Multidrug Resistance-Associated Proteins MRP1, MRP2, MRP3, and MRP4

  2011cited by this paper
• Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs

  2011cited by this paper
• Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).

  2011cited by this paper
• The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double‐blind, randomized, placebo‐controlled trial

  2010cited by this paper
• 1102 THE POTENT BILE ACID SEQUESTRANT COLESEVELAM (CHOLESTAGEL®) IS NOT EFFECTIVE IN CHOLESTATIC PRURITUS. RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED TRIAL

  2010cited by this paper
• Inhibition of Na+-Taurocholate Co-transporting Polypeptide-mediated Bile Acid Transport by Cholestatic Sulfated Progesterone Metabolites*

  2010cited by this paper
• In Vitro Investigation of the Hepatobiliary Disposition Mechanisms of the Antifungal Agent Micafungin in Humans and Rats

  2010cited by this paper
• Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter.

  2009influential reference
• Bile acid transporters in health and disease

  2008cited by this paper
• Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines

  2007cited by this paper
• Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity

  2007cited by this paper
• Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs

  2006cited by this paper
• Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

  2006cited by this paper
• Hepatobiliary transporters and drug‐induced cholestasis

  2006cited by this paper
• HEPATIC UPTAKE OF THE NOVEL ANTIFUNGAL AGENT CASPOFUNGIN

  2005cited by this paper
• Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates

  2004cited by this paper
• Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.

  2004cited by this paper
• Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition*

  2004cited by this paper
• Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group

  2004cited by this paper
• Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells.

  2000cited by this paper
• Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na(+)/bile acid cotransporter.

  1999cited by this paper
• Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

  1999cited by this paper
• Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters.

  1999cited by this paper
• Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver

  1997cited by this paper
• Alteration of cAMP-mediated hormonal responsiveness by bile acids in cells of nonhepatic origin.

  1995cited by this paper
• Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.

  1993cited by this paper
• Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles

  1984cited by this paper
• Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

  1969cited by this paper

• Refining Drug-Induced Cholestasis Prediction: An Explainable Consensus Model Integrating Chemical and Biological Fingerprints

  2025cites this paper
• Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms

  2024influential citation
• Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System

  2021cites this paper
• Na+-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment

  2021cites this paper
• Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters

  2021cites this paper
• Title: Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters

  2021influential citation
• Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids

  2020cites this paper
• The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease.

  2019cites this paper
• In Silico Approaches to Predict Drug-Transporter Interaction Profiles: Data Mining, Model Generation, and Link to Cholestasis.

  2019cites this paper
• Mechanisms and in vitro models of drug-induced cholestasis

  2019cites this paper
• Transporters in Hepatotoxicity

  2018cites this paper
• Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters—An in Silico Modeling Approach

  2017cites this paper
• Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP

  2017cites this paper
• Screening and verifying potential NTCP inhibitors from herbal medicinal ingredients using the LLC-PK1 cell model stably expressing human NTCP.

  2016cites this paper
• Non-invasive visualisation and quantification of (disturbed) hepatobiliary transport

  2016cites this paper
• Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.

  2015cites this paper
• A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide.

  2015influential citation
• Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.

  2015cites this paper
• Making Transporter Models for Drug–Drug Interaction Prediction Mobile

  2015cites this paper
• In silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond.

  2015cites this paper
• PET Tracers To Study Clinically Relevant Hepatic Transporters.

  2015cites this paper
• DMD064956 1642..1645

  2015cites this paper
• Drug‐Induced Hepatotoxicity: Advances in Preclinical Predictive Strategies and Tools

  2014cites this paper
• Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition.

  2014cites this paper
• Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools

  2014cites this paper
• In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.

  2014cites this paper
• Electrophysiological characterization of human Na⁺/taurocholate cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus laevis oocytes.

  2014cites this paper
• Genetic variations of bile salt transporters.

  2014cites this paper
• Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).

  2013cites this paper
• Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters

  2013cites this paper
• An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

  2013cites this paper
• Virtual screening methods as tools for drug lead discovery from large chemical libraries.

  2012cites this paper
• The SLC10 carrier family: transport functions and molecular structure.

  2012cites this paper